We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Eco Animal Health Group Plc | LSE:EAH | London | Ordinary Share | GB0032036807 | ORD 5P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 94.00 | 93.00 | 95.00 | 94.00 | 94.00 | 94.00 | 10,460 | 08:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Chem,fertlizer Minrl Mng,nec | 85.31M | 1.01M | 0.0149 | 63.09 | 63.68M |
From Apr 2019 to Apr 2024
TIDMEAH
ECO Animal Health Group plc ("ECO")
(AIM: EAH)
Directorate Change
ECO Animal Health Group plc (the "Group") announces that Richard Wood is stepping down as Non-executive Chairman and will be leaving the board of the Company with immediate effect.
Since joining Richard has successfully implemented significant changes including reshaping the board and its processes.
The board will now commence a search for a new chairman.
Following Richard's departure and whilst the board seeks to appoint a permanent replacement, Andrew Jones, the Senior Non-executive director, will act as interim Chairman.
Marc Loomes, CEO of ECO, commented "I would like to thank Richard for his significant contribution and wish him well for the future"
Enquiries:
ECO Animal Health Group plc Tel: Andrew Jones 07771 903917 Marc Loomes 020 84478899 N+1 Singer (Nominated Adviser and Joint Broker) Tel: 020 7496 3000 Mark Taylor James White Peel Hunt (Joint Broker) Tel: 020 7418 8900 James Steel Dr Christopher Golden IFC Advisory Tel: 020 3934 6637 Graham Herring Miles Nolan
About ECO Animal Health Ltd
ECO Animal Health based in London U.K. is a leader in the development, registration and marketing of pharmaceutical products for global animal health markets. Its products for these growth markets promote well-being in animals and include the novel antimicrobial, Aivlosin®, as well as a range of generic therapeutic products.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190821005615/en/
This information is provided by Business Wire
(END) Dow Jones Newswires
August 22, 2019 02:00 ET (06:00 GMT)
1 Year Eco Animal Health Chart |
1 Month Eco Animal Health Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
